If you've had an annual checkup recently, your doctor probably ran a blood test to look at things such as your cholesterol ...

Regeneron and Tessera partner on TSRA-196, a one-time gene writing therapy targeting alpha-1 antitrypsin deficiency with FDA ...

Preclinical mRNA therapy using peptibodies enhances bacterial clearance and immune response in multidrug-resistant pneumonia ...

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ...

RNA therapy encoding antimicrobial peptibodies reduces drug-resistant pneumonia severity in preclinical models and boosts ...

LipidVerse 2025, a pivotal one-day conference at IIT Bombay, highlighted the latest advances in lipid-based nanotechnology for pharmaceuticals. With key discussions on gene delivery, cancer therapy, ...

Early CRISPR treatment showed major cholesterol reduction in just two weeks * High-dose therapy led to about a fifty percent ...

Five years ago this month, in November 2020, medical history was made at Richmond Pharmacology when a patient received the ...

Inhaled lipid nanoparticles loaded with two medicines reduced IPF lung stiffness and fibrosis in mice, outperforming an ...

TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria.